AQEMIA is a next-gen pharmatech company generating one of the world's fastest-growing drug discovery pipeline. Our mission is to design fast innovative drug candidates for dozens of critical diseases, such as immuno-oncology.

Our unique approach leverages quantum-inspired physics algorithms to power generative AI in designing novel drug candidates—without relying on experimental data. We already delivered several drug discovery successes within our internal pipeline and through collaborations with pharmaceutical companies.
Our most advanced programs are currently in vivo optimization.

AQEMIA is based in Paris and London.

AI/ML

Biotechnology

Chemicals

Pharmaceutical

Software

AQEMIA

Paris

London

This department focuses on building and maintaining the infrastructure and architecture necessary for data generation, collection, and processing.

Data Engineering

This department focuses on designing, building, and maintaining software applications and systems.

Software Development

This department focuses on applying computational methods to advance drug discovery and development.

Computational Chemistry

This department focuses on researching and developing new drugs and therapies.

Drug Discovery

This department oversees the planning, execution, and delivery of projects to ensure alignment with organizational goals.

Program Management

This department focuses on advancing artificial intelligence through scientific research and application.

People (5)

Jobs (0)

Other teams

Software Development

Computational Chemistry

Drug Discovery

Program Management

AI Research